Back to top

TeleTech Expands to Texas

Read MoreHide Full Article

TeleTech Holdings Inc. (TTEC - Free Report) recently announced its plans to expand operations to Ennis, Texas, to serve the company’s ever increasing healthcare clients. The company currently intends to create 400 new healthcare-related sales and service jobs. Additionally, TeleTech also plans to create 250 similar jobs at its new sister concern’s office in Melbourne, FL.

For the healthcare related sales jobs in Texas, TeleTech plans to hire 150 candidates. All candidates having a state health insurance sales license of Texas are ideally suitable for the positions. However, TeleTech is also open to hiring unlicensed candidates whom it will provide training and help them secure license under TeleTech’s Healthcare Insurance Career Development Program. The company will be bearing the entire costs of training to equip the new hires with a valuable certification.

TeleTech plans to fill the remaining vacancies in Texas by hiring unlicensed candidates for service-related customer support jobs. Moreover, of the total 400 positions, TeleTech plans to fill two-thirds of them by hiring seasonal employees under the Medicare Open Enrollment ramp. However, the remaining positions will be full time.

TeleTech intends to continue adding employees in the long run, till the Texas site reaches its full capacity of 700+ employees.

TeleTech provides technology-enabled solution to its customers, which helps its client companies to maximize their revenue, transform customer experience and build an optimum business model. The company serves more than 250 clients in sectors like automotive, broadband, communications, financial services, government, healthcare, logistics, media and entertainment, retail.

TeleTech currently carries a Zacks Rank #3 (Hold). Better positioned stocks within the industry worth considering include Sykes Enterprises, Incorporated ( ">SYKE ),  Portfolio Recovery Associates Inc. (PRAA - Free Report) and Genpact Ltd. (G - Free Report) . While Sykes carries a Zacks Rank #1 (Strong Buy), Portfolio Recovery and Genpact carry a Zacks Rank #2 (Buy).

More from Zacks Analyst Blog

You May Like